Kyle Jacques Rose

In 2012, Kyle created the mySugr Delta PM joint venture launching mySugr’s world-leading mHealth platform. Both a healthcare industry veteran and avid patient advocate, he has worked tirelessly with governments and health ministries to enable access to medication and technology for people with diabetes around the world. Kyle Jacques is part of INSEAD’s Health Care Management faculty (EiR) where he focuses on innovation in diabetes therapy, patient community collaboration, and training of health care professionals. He is particularly interested in the aspect of patient engagement and motivation for better treatment outcomes.

 Prior to his current role, he served as presenting faculty at Stanford University’s School of Medicine and College of Engineering BioDesign. Kyle has worked for leading pharmaceutical and medical device companies including Abbott, J&J, Medtronic, and Sanofi. He also has worked with NGOs such as Team Type 1 (now Team Novo Nordisk) where he was a founding team member and director.

 Kyle has held positions in research and development, sales and marketing, and general management. He earned his B.S. in Chemical Engineering from Cornell University in New York and his Masters of Business Administration (MBA) from INSEAD in France and Singapore.